Biomarkers Market Size to Reach USD 97.51 billion at 12.1% CAGR Forecast 2021-2026
The above information is given by Fortune Business Insights™ in a recent study, titled, “Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the biomarker market size was USD 39.10 billion in 2018 and is projected to reach USD 97.51 billion by 2026, thereby exhibiting a CAGR of 12.1% during the forecast period.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/biomarkers-market-102173
Key Players Operating in The Biomarkers MarketInclude:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc.
Sino Biological Inc.
Other key market players
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Highlights of the Report:
In-depth analysis of various insights, namely, Biomarkers Markettrends, growth drivers, opportunities, and other related challenges.
Comprehensive details of key market players, their core competencies, and Biomarkers Marketshare.
The potency of suppliers and buyers to make better business decisions.
Lists out the market size in terms of volume.
Increasing Demand for Personalized Medicine to Accelerate Growth
Biomarkers are increasingly used in disease diagnostics. They also play an important role in development of personalized medicine for several disease conditions. Disease diagnosis and treatment procedures possess certain limitations and because of this, the concept of personalized medicine is becoming popular nowadays. Patients suffering from immunological disorders and cancer are rapidly inclining towards customized treatment options based on their genetic and clinical features. It would propel the biomarkers market growth during the forecast period.
Oncology Segment to Grow Steadily Backed by Rising Prevalence of Chronic Diseases
In terms of indication, the market is grouped into oncology, cardiology, neurology and others. Out of these, the oncology segment dominated the market in 2018. This growth is attributable to the increasing cases of cancer. Growing demand for personalized medicine in diagnosis and treatment of cancer, along with increasing number of new biomarker based assays and tests being introduced by market players, is propelling the growth of oncology segment. Rising prevalence of neurological disorders and increasing investment by key market players in the development of neurology biomarkers are is one of the major factor anticipated to drive the growth of the segment at faster rate.
Detailed Table of Content:
Definitions and Assumptions
New Product Launches, by Key Market Players
Prevalence by Disease Indication, By Key Countries/ Region, 2018
Incidence of Cancer, By Key Countries/ Key Region,2018
Key industry Developments - Mergers, Acquisitions and Partnerships
Overview of Biomarkers In Personalized Medicine
Global Biomarkers Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Indication
Market Analysis, Insights and Forecast – By End User
Pharmaceutical & Biotechnology Companies
Diagnostics & Research Laboratories
Hospitals & Specialty Clinics
Market Analysis, Insights and Forecast – By Region
Middle East & Africa
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/biomarkers-market-102173
Extensive product offerings
Customer research services
Robust research methodology
Latest technological developments
Value chain analysis
Potential Biomarkers Marketopportunities
Regular report updates
Reasons to Purchase this Report:
Comprehensive analysis of the Biomarkers Marketgrowth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.
KEY QUESTIONS ANSWERED:
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the Biomarkers Marketgrowth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune - 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Market Size to Reach USD 97.51 billion at 12.1% CAGR Forecast 2021-2026 here
News-ID: 2377720 • Views: 271
More Releases from Fortune Business Insights Pvt. Ltd.
Key Companies Covered in the Connected Drug Delivery Devices Market Research Rep …
The global “connected drug delivery devices market size” is projected to reach USD 4,062.7 million by 2026, exhibiting a CAGR of 35.4% during the forecast period. However, the market size was USD 361.1 million in 2018. This information is published in a recent report by Fortune Business Insights™, titled, “Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology
Key Companies Covered in the Hip Replacement Market Research Report are Raw mate …
The global hip replacement market size will increase with the advent of robot-assisted surgical procedures worldwide. Fortune Business Insights™ in their recent report titled, “Hip Replacement Market Size, Share & Industry Analysis, By Procedure (Total Hip Replacement, Partial Hip Replacement, and Revision & Hip Resurfacing), By End User (Hospitals & Ambulatory Surgery Centers, Orthopedic Clinics, and Others) and Regional Forecast, 2019-2026”, provides a comprehensive analysis of the market and their
Key Companies Covered in the Gene Therapy Market Research Report are Novartis AG …
The global gene therapy market is set to gain momentum from the rising incidence of different types of cancer. The field of this therapy is undergoing several technological advancements that would help in treating cancer in those patients who are at high risks of getting affected by this disease through genetic mutations. Fortune Business Insights™ provided this information in a new report, titled, “Gene Therapy Market Size, Share & COVID-19
Medical Transcription Software Market Size and Detailed Analysis Focusing On Key …
The global medical transcription software market size will benefit from the growing penetration of technology and automation in several applications across the healthcare industry. According to a report published by Fortune Business Insights, titled “Medical Transcription Software Market Size, Share & Industry Analysis, By Deployment (Cloud/Web-based and Installed/On-Premises), By End User Facility (Hospitals, Diagnostic Centers, Clinics, and Others), By Type (Voice Capture and Voice Recognition), By End User (Radiologists, Surgeons,
More Releases for Biomarkers
Biomarkers Market Fragmented by 2025
Global Biomarkers Market: Snapshot The global biomarkers market is witnessing a tremendous rise in its valuation, thanks to the increase in diagnostic applications of biomarkers. The augmenting investments for research and development activities in the pharma and biotech companies, rising number of CROs, and the low cost associated with the clinical trials in emerging economies are also boosting this market. Going forward, the high prevalence rate of cancer and novel initiatives for
Cancer Biomarkers Market: Regional Overview
Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Cancer therapies are expensive and the cost rises with increase in complexity or stage
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Biomarkers Market : Analysis & Trends 2023
Global Biomarkers Market A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions
Global Vocal Biomarkers Market
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Mental and physical conditions such as anxiety
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out